What is the appropriate treatment for a patient with Sweet syndrome who has back pain?

Treatment of Back Pain in Sweet Syndrome

The back pain in Sweet syndrome should be treated with systemic corticosteroids as the primary therapy for the underlying Sweet syndrome, which will address both the dermatologic manifestations and associated musculoskeletal symptoms including back pain. 1, 2

Understanding the Clinical Context

Sweet syndrome (acute febrile neutrophilic dermatosis) is a systemic inflammatory condition that can present with musculoskeletal manifestations including arthralgias and back pain alongside the characteristic fever, neutrophilia, and tender erythematous skin lesions 1, 2. The back pain in this context is part of the systemic inflammatory process, not mechanical low back pain.

Critical Distinction

The provided evidence on low back pain management [3-4] addresses mechanical or nonspecific low back pain and is not applicable to inflammatory back pain associated with Sweet syndrome. Applying standard low back pain guidelines would be inappropriate and potentially harmful, as they specifically recommend against systemic corticosteroids for mechanical low back pain 3, whereas corticosteroids are the gold standard for Sweet syndrome.

Recommended Treatment Algorithm

First-Line Therapy: Systemic Corticosteroids

• Oral prednisone 1 mg/kg/day is the gold standard treatment 2
• Expect dramatic improvement of fever, arthralgias, and back pain within 48 hours 5
• Skin lesions typically clear within 7-14 days 5
• After initial response, taper the dose gradually to prevent relapse

Rationale: Systemic corticosteroids address the underlying neutrophilic inflammatory process causing both the dermatologic and musculoskeletal manifestations 1, 2. The back pain will resolve as the systemic inflammation is controlled.

Alternative First-Line Options (When Corticosteroids Contraindicated)

If the patient has contraindications to corticosteroids (such as active infection, uncontrolled diabetes, or severe osteoporosis):

1. Potassium iodide - typically results in rapid resolution 1, 2
2. Colchicine - effective alternative with rapid response 1, 2
3. Indomethacin 150 mg/day for 1 week, then 100 mg/day for 2 additional weeks - demonstrated 94% response rate (17/18 patients) with fever and arthralgias markedly attenuated within 48 hours 5

Second-Line Therapies (For Refractory Cases)

• Dapsone (requires G6PD screening and monitoring for hemolysis)
• Cyclosporine (requires renal and blood pressure monitoring)
• Clofazimine
• IL-1 receptor antagonist (anakinra) for cases with identified IL-1 pathway hyperactivation 6

Common Pitfalls to Avoid

1. Do not treat as mechanical low back pain - NSAIDs alone, acetaminophen, muscle relaxants, or physical therapy will not address the underlying inflammatory process
2. Do not use systemic corticosteroids for isolated back pain - ensure Sweet syndrome diagnosis is confirmed first with appropriate clinical and histopathologic criteria
3. Monitor for relapse - approximately one-third of classical Sweet syndrome cases experience recurrence after treatment discontinuation 2
4. Rule out malignancy-associated Sweet syndrome - particularly in patients over 50 or with atypical presentations, as this may require treatment of underlying malignancy 2

Monitoring Response

• Fever and back pain should improve within 48 hours of initiating therapy 5
• If no improvement by 48-72 hours, reassess diagnosis and consider alternative or additional therapy
• Follow inflammatory markers (ESR, CRP) and neutrophil count to guide treatment duration

The back pain is a manifestation of the systemic inflammatory process of Sweet syndrome and will resolve with appropriate treatment of the underlying condition, not with standard mechanical back pain interventions.